A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07033169
- Status
- Recruiting
Conditions
- Dermatologic Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study
Key Dates
- Start date
- Sep 15, 2025
- Status verified
- Oct 2025
- Primary completion
- Sep 30, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Patient at Advocate Health dermatology clinicThe study, subject recruitment, and analysis will be conducted within the Advocate Health system at Atrium Health Wake Forest Baptist (AHWFB) in Winston-Salem, NC. Recruiters for this study include Advocate Health dermatology attendings, fellows, and staff, who will capture images of patients presenting to Wake Forest Dermatology Clinics in Winston-Salem, NC.
Primary Outcome Measure
concordance of Belle.ai diagnoses with physician diagnoses. [ Time Frame: Day 1 ]
Central Contacts
- Irma M Richardson, MHA336-716-2903
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences Department of Dermatology | Winston-Salem | North Carolina | 27157 | Lindsay C Strowd, MD, (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Winston-Salem, NC
Related Studies
- Collection and Distribution of Biospecimens for Novel Research UsesRecruiting · iSpecimen Inc · Huntsville, Alabama
- A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · Recruiting · Apollo Therapeutics Ltd · Birmingham, Alabama